Get the Stockscreener App
2.00
0.76%
0.015
After Hours:
1.90
-0.10
-5.00%
Standard Biotools Inc Stock (LAB) Forecast
The Standard Biotools Inc (LAB) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.898, representing a -55.10% decrease from the current price of $2.00. The highest analyst price target is $1.1436, and the lowest is $0.6524.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LAB Price Target
Average 1.6951
(-15.24% Downside)
Is Standard Biotools Inc (LAB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 54.24 | Neutral |
| STOCH(9,6) | 62.72 | Neutral |
| STOCHRSI(14) | 37.97 | Neutral |
| MACD(12,26) | 0.0563 | Buy |
| ADX(14) | 22.31 | Neutral |
| William %R | -48.08 | Neutral |
| CCI(14) | 18.68 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.004
Sell
|
1.9862
Buy
|
| MA20 |
1.8915
Buy
|
1.9334
Buy
|
| MA50 |
1.8744
Buy
|
1.8984
Buy
|
| MA100 |
1.8763
Buy
|
1.9393
Buy
|
| MA200 |
2.1374
Sell
|
2.0449
Sell
|
Buy: 7
Sell: 3
Neutral: 0
Summary: Buy
According to our latest analysis, LAB could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 3 signaling Sell signals and 6 Neutral signals. This might be a good time to open fresh positions on LAB, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 54.24 indicates that LAB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 62.72 indicates that LAB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 37.97 indicates that LAB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 22.31 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 18.68 indicates that LAB is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term LAB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Standard Biotools Inc financial reports and earnings history, Standard Biotools Inc (LAB) stock could reach $1.3519 by 2030, $0.1276 by 2040 and $3.2116 by 2050. See the projected annual prices until 2050 of the Standard Biotools Inc stock below:
- Standard Biotools Inc (LAB) is expected to reach an average price of $0.1037 in 2035, with a high prediction of $0.1393 and a low estimate of $0.1945. This indicates an $-94.82% rise from the last recorded price of $2.00.
- Standard Biotools Inc (LAB) stock is projected to chart a bullish course in 2040, with an average price target of $0.0624, representing an $-96.88% surge from its current level. The forecast ranges from a conservative $0.1768 to a sky-high $0.1276.
- Our analysts predict Standard Biotools Inc (LAB) to jump 59.59% by 2045, soaring from $3.1918 to an average price of $3.1918, potentially reaching $3.1243. While $3.1918 is the low estimate, the potential upside is significant.
- Standard Biotools Inc (LAB) stock is expected to climb by 2050, reaching an average of $3.2616, a $63.08% jump from its current level. However, a wide range of estimates exists, with high and low targets of $3.2116 and $3.3216, respectively, highlighting the market's uncertainty.
Standard Biotools Inc Stock (LAB) Year by Year Forecast
Standard Biotools Inc Stock (LAB) Price Forecast for 2025
Standard Biotools Inc Stock (LAB) is expected to reach an average price of $1.6951 in 2025, with a high prediction of $2.7379 and a low estimate of $0.6524. This indicates an -15.24% fall from the last recorded price of $2.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $1.1036 | $0.6524 | $1.1436 | -44.82% |
| February, 2025 | $1.5561 | $1.0643 | $1.7333 | -22.19% |
| March, 2025 | $1.3486 | $1.3386 | $1.738 | -32.57% |
| April, 2025 | $1.6317 | $1.2699 | $1.9405 | -18.41% |
| May, 2025 | $1.3142 | $1.273 | $1.6423 | -34.29% |
| June, 2025 | $1.8567 | $1.0255 | $1.9567 | -7.17% |
| July, 2025 | $1.7098 | $1.6848 | $2.2173 | -14.51% |
| August, 2025 | $1.9223 | $1.4517 | $2.0623 | -3.89% |
| September, 2025 | $2.1148 | $1.8735 | $2.1435 | +5.74% |
| October, 2025 | $2.6279 | $1.9054 | $2.7379 | +31.39% |
| November, 2025 | $2.4804 | $2.1804 | $2.6885 | +24.02% |
| December, 2025 | $1.5735 | $1.1522 | $2.551 | -21.33% |
Standard Biotools Inc Stock (LAB) Price Forecast for 2026
The predicted value for Standard Biotools Inc (LAB) in 2026 is set at an average of $1.4926. Estimates vary from a peak of $2.6403 to a trough of $0.3449, indicating an -25.37% surge from the present price of $2.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.026 | $1.4247 | $2.061 | +1.30% |
| February, 2026 | $1.5785 | $1.5435 | $2.2378 | -21.08% |
| March, 2026 | $1.7409 | $1.3253 | $1.9303 | -12.95% |
| April, 2026 | $1.9841 | $1.6416 | $2.0991 | -0.80% |
| May, 2026 | $2.0965 | $1.8265 | $2.2303 | +4.83% |
| June, 2026 | $2.309 | $2.0272 | $2.5072 | +15.45% |
| July, 2026 | $2.0821 | $1.7715 | $2.6403 | +4.11% |
| August, 2026 | $0.9525 | $0.7012 | $2.2128 | -52.38% |
| September, 2026 | $0.6687 | $0.6337 | $1.215 | -66.56% |
| October, 2026 | $0.5437 | $0.5037 | $0.9512 | -72.82% |
| November, 2026 | $0.6387 | $0.3549 | $1.1487 | -68.07% |
| December, 2026 | $0.4349 | $0.3449 | $0.6699 | -78.26% |
Standard Biotools Inc Stock (LAB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Standard Biotools Inc (LAB) is $0.9004, with a high forecast of $1.7846 and a low forecast of $0.0161. This indicates an -54.98% decrease from the last price of $2.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.1199 | $0.0799 | $0.4861 | -94.01% |
| February, 2027 | $0.2148 | $0.0911 | $0.4048 | -89.26% |
| March, 2027 | $0.611 | $0.0161 | $0.6623 | -69.45% |
| April, 2027 | $0.276 | $0.2048 | $0.6535 | -86.20% |
| May, 2027 | $1.241 | $0.2673 | $1.241 | -37.95% |
| June, 2027 | $0.9072 | $0.8972 | $1.296 | -54.64% |
| July, 2027 | $1.2222 | $0.8297 | $1.5009 | -38.89% |
| August, 2027 | $0.9272 | $0.8359 | $1.3939 | -53.64% |
| September, 2027 | $1.4234 | $0.5909 | $1.5234 | -28.83% |
| October, 2027 | $1.3584 | $1.3184 | $1.7846 | -32.08% |
| November, 2027 | $1.2433 | $1.0233 | $1.4295 | -37.83% |
| December, 2027 | $1.6896 | $1.2846 | $1.7171 | -15.52% |
Standard Biotools Inc Stock (LAB) Price Forecast for 2028
In 2028, Standard Biotools Inc (LAB) is projected to reach an average price of $1.2676, with a high projection of $2.3158 and a low estimate of $0.2193. This indicates an -36.62% fall from the last price of $2.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.1545 | $1.4808 | $2.2795 | +7.73% |
| February, 2028 | $1.9395 | $1.7895 | $2.3158 | -3.02% |
| March, 2028 | $0.9857 | $0.7345 | $2.132 | -50.71% |
| April, 2028 | $1.4107 | $0.982 | $1.4707 | -29.46% |
| May, 2028 | $1.1669 | $1.1319 | $1.8257 | -41.65% |
| June, 2028 | $1.3319 | $0.9157 | $1.5207 | -33.41% |
| July, 2028 | $1.6169 | $1.2331 | $1.6844 | -19.16% |
| August, 2028 | $1.6931 | $1.4231 | $1.8256 | -15.35% |
| September, 2028 | $1.9081 | $1.6243 | $2.1043 | -4.60% |
| October, 2028 | $1.643 | $1.373 | $2.2406 | -17.85% |
| November, 2028 | $0.4837 | $0.2319 | $1.8155 | -75.81% |
| December, 2028 | $0.3512 | $0.2193 | $0.7475 | -82.44% |
Standard Biotools Inc Stock (LAB) Price Forecast for 2029
The 2029 price forecast for Standard Biotools Inc Stock (LAB) is $0.5315 on average, with a high prediction of $1.0614 and a low estimate of $0.00157. This represents an -73.43% decrease from the previous price of $2.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.0805 | $0.0405 | $0.4868 | -95.97% |
| February, 2029 | $0.178 | $0.0157 | $0.688 | -91.10% |
| March, 2029 | $0.0155 | $0.00548 | $0.2099 | -99.23% |
| April, 2029 | $0.1971 | $0.1127 | $0.129 | -90.15% |
| May, 2029 | $0.2378 | $0.2496 | $0.2334 | -88.11% |
| June, 2029 | $0.0397 | $0.0803 | $0.211 | -98.01% |
| July, 2029 | $0.00717 | $0.00157 | $0.2053 | -99.64% |
| August, 2029 | $0.7965 | $0.1728 | $0.7965 | -60.18% |
| September, 2029 | $0.764 | $0.5802 | $0.854 | -61.80% |
| October, 2029 | $0.7833 | $0.3896 | $1.0614 | -60.84% |
| November, 2029 | $0.4908 | $0.3989 | $0.9557 | -75.46% |
| December, 2029 | $0.4682 | $0.1564 | $0.5982 | -76.59% |
Standard Biotools Inc Stock (LAB) Price Forecast for 2030
Standard Biotools Inc Stock (LAB) is expected to reach an average price of $1.1052 in 2030, with a high forecast of $1.8937 and a low forecast of $0.3167. This signifies an -44.74% decrease from the last price of $2.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.9275 | $0.4514 | $1.3519 | -53.62% |
| February, 2030 | $0.815 | $0.595 | $0.9993 | -59.25% |
| March, 2030 | $1.1725 | $0.8569 | $1.2906 | -41.38% |
| April, 2030 | $1.3299 | $1.0562 | $1.7581 | -33.50% |
| May, 2030 | $1.5193 | $1.2218 | $1.8937 | -24.04% |
| June, 2030 | $0.7867 | $0.3167 | $1.713 | -60.66% |
| July, 2030 | $0.9961 | $0.5586 | $1.0561 | -50.20% |
| August, 2030 | $1.0035 | $0.9323 | $1.4135 | -49.82% |
| September, 2030 | $0.641 | $0.506 | $1.111 | -67.95% |
| October, 2030 | $1.2103 | $0.5928 | $1.2766 | -39.48% |
| November, 2030 | $1.0378 | $1.0228 | $1.4209 | -48.11% |
| December, 2030 | $1.4752 | $1.0196 | $1.7015 | -26.24% |
1.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):